You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 27, 2025

Drugs Containing Excipient (Inactive Ingredient) METHIONINE


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing METHIONINE excipient, and estimated key patent expiration / generic entry dates

Generic drugs containing METHIONINE excipient

Market Dynamics and Financial Trajectory for the Pharmaceutical Excipient: Methionine

Introduction to Methionine in Pharmaceutical Applications

Methionine, an essential amino acid, plays a crucial role in various industries, including pharmaceuticals. Its application in pharmaceuticals is multifaceted, from being a nutritional additive in animal feed to serving as an excipient in drug formulations.

Global Methionine Market Overview

The global methionine market is projected to experience significant growth. As of 2022, the market value was USD 4.11 billion, and it is expected to reach USD 6.45 billion by 2030, growing at a CAGR of 5.8% during the forecast period of 2023 to 2030[1].

Segmentation and Dominant Sectors

The methionine market is segmented into various types, including plant-based and animal-based segments. In 2023, the plant-based segment is expected to dominate the market due to increasing awareness towards vegan diets and rising health and fitness consciousness[1].

Animal Feed Sector

Methionine is widely used in animal feed as a nutritional additive to meet the health requirements of livestock. The demand from the aquaculture and poultry industries is a significant driver for the methionine market. Asia Pacific, led by China, and North America are key regions driving this demand due to high consumption rates of meat products and the subsequent need for animal feed[4].

Pharmaceutical Sector

In the pharmaceutical industry, methionine serves as an excipient, helping in the formulation of drugs. Its role in preventing aggregation in protein-based formulations is particularly noteworthy. Research indicates that optimizing excipient properties, such as those of methionine, can prevent protein aggregation, which is crucial for the stability and efficacy of pharmaceutical products[5].

Geographical Distribution

The methionine market is geographically dominated by the Asia Pacific region, particularly China, due to its large population and growing middle class. This region's demand for meat products and consequently animal feed has escalated, driving the demand for methionine. North America also shows rapid growth, attributed to high consumption rates of poultry and the use of methionine in animal feed[4].

Market Drivers

Several factors drive the growth of the methionine market:

Increasing Demand for Animal Feed

The growing demand for meat products globally has led to an increased need for nutritional additives in animal feed, driving the demand for methionine[4].

Rising Health and Fitness Awareness

The increasing awareness towards health and fitness, particularly the trend towards vegan diets, has boosted the demand for plant-based methionine[1].

Technological Advancements

The shift towards eco-friendly extraction processes and the rising popularity of bio-based products are expected to continue driving the market expansion[4].

Financial Trajectory

Revenue Growth

The global methionine market is expected to grow from USD 4.11 billion in 2022 to USD 6.45 billion by 2030, with a CAGR of 5.8% during the forecast period. This growth is driven by increasing demand across various sectors, including animal feed and pharmaceuticals[1].

Profitability and Cost Rationalization

Companies involved in the methionine market are focusing on cost rationalization and profitability improvement. For instance, Sumitomo Chemical achieved annual cost rationalizations of 2 billion yen through initiatives such as optimizing sales regions and cutting research expenses[2].

Supply Chain and Demand Dynamics

The methionine market has faced challenges such as logistics disruptions due to the pandemic and the shutdown of rival plants. However, the demand has continued to show strength, particularly in the pharmaceutical and animal feed sectors. The rising market prices of methionine are a testament to its increasing demand and supply chain dynamics[2].

Challenges and Opportunities

Supply Chain Disruptions

Logistics disruptions and the shutdown of rival plants have posed challenges to the methionine market. However, these disruptions also present opportunities for companies to optimize their supply chains and improve their market position[2].

Regulatory Environment

The regulatory environment, particularly in the pharmaceutical sector, can impact the use of methionine as an excipient. Compliance with regulatory standards is crucial for maintaining market share and expanding into new regions[5].

Technological Innovations

The adoption of eco-friendly extraction processes and the development of bio-based products offer lucrative opportunities for stakeholders in the methionine market. These innovations can help in reducing costs, improving efficiency, and meeting the growing demand for sustainable products[4].

Key Players and Market Strategies

Major players in the methionine market are focusing on strategic initiatives such as expanding their product portfolios, optimizing sales regions, and improving financial strength. For example, Sumitomo Chemical has implemented a profitability improvement campaign and has made significant strides in cost rationalization and supply chain optimization[2].

Conclusion

The methionine market, driven by its diverse applications in animal feed and pharmaceuticals, is poised for significant growth. With a projected CAGR of 5.8% from 2023 to 2030, the market presents lucrative opportunities for stakeholders. However, it also faces challenges such as supply chain disruptions and regulatory compliance. By focusing on cost rationalization, technological innovations, and strategic market initiatives, companies can navigate these challenges and capitalize on the growing demand for methionine.

Key Takeaways

  • The global methionine market is expected to grow from USD 4.11 billion in 2022 to USD 6.45 billion by 2030.
  • The plant-based segment is expected to dominate the market due to increasing health and fitness awareness.
  • The animal feed sector, particularly in Asia Pacific and North America, drives significant demand for methionine.
  • Technological advancements and eco-friendly extraction processes are key drivers for market growth.
  • Supply chain disruptions and regulatory compliance are significant challenges.
  • Major players are focusing on cost rationalization and strategic market initiatives.

FAQs

What is the projected growth rate of the global methionine market from 2023 to 2030?

The global methionine market is expected to grow at a CAGR of 5.8% from 2023 to 2030[1].

Which segment is expected to dominate the methionine market in 2023?

The plant-based segment is expected to dominate the methionine market in 2023 due to increasing awareness towards vegan diets and health and fitness[1].

What are the primary drivers of the methionine market?

The primary drivers include increasing demand for animal feed, rising health and fitness awareness, and technological advancements towards eco-friendly extraction processes[1][4].

How does the methionine market impact the pharmaceutical industry?

Methionine serves as an excipient in pharmaceutical formulations, helping to prevent protein aggregation and ensuring the stability and efficacy of drug products[5].

What challenges does the methionine market face?

The methionine market faces challenges such as logistics disruptions, rival plant shutdowns, and regulatory compliance issues[2].

Sources

  1. Data Bridge Market Research, "Global Methionine Market – Industry Trends and Forecast to 2030".
  2. Sumitomo Chemical, "Current Priority Management Issues and Business Strategy".
  3. BioSpace, "Pharmaceutical Excipients Market Size USD 14.72 Billion by 2033 and CAGR 5.81 Percent".
  4. Mordor Intelligence, "Methionine Market Size & Share Analysis".
  5. ACS Publications, "Optimizing Excipient Properties to Prevent Aggregation in Protein-Based Formulations".

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.